Compare BIIB to:
Real-Time: 47.46 0.08 (0.17%) 11:22am ET
| Last Trade: | 47.47 |
|---|---|
| Trade Time: | 11:08am ET |
| Change: | |
| Prev Close: | 47.38 |
| Open: | 47.24 |
| Bid: | 47.46 x 200 |
| Ask: | 47.47 x 900 |
| 1y Target Est: | 49.67 |
| Day's Range: | 47.18 - 47.70 |
|---|---|
| 52wk Range: | 39.01 - 55.34 |
| Volume: | 484,139 |
| Avg Vol (3m): | 3,317,670 |
| Market Cap: | 13.73B |
| P/E (ttm): | 15.89 |
| EPS (ttm): | 2.99 |
| Div & Yield: | N/A (N/A) |
| Wed 6:50am | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.GlobeNewswire |
| Mon, Nov 23 | [$$] Fitz Bits: Wait for a Retest in Fordat RealMoney by TheStreet.com |
| Mon, Nov 23 | A Big Upgrade for Allos Therapeuticsat Motley Fool |
| Mon, Nov 23 | Icahn Makes Big Moves in Healthcare StocksIndie Research |
| Fri, Nov 20 | UPDATE - HealthCor slams Biogen CEO for outsize pay packageat Reuters |
| Fri, Nov 20 | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research AnalystWall Street Transcript |
| Thu, Nov 19 | This Stock Is a Train Wreckat Motley Fool |
| Wed, Nov 18 | Genentech, Biogen get FDA request on RituxanAP |
| Tue, Nov 17 | [$$] Activity Jumps in Biotech and Drug Firmsat The Wall Street Journal Online |
| Tue, Nov 17 | Genzyme's Termeer: Worst Biotech CEO of '09at TheStreet.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.